Sort
51,593 grants matching “hepatitis”
Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics
$564,499Sonia Michael Najjar · Ohio University Athens · R01 · FY2023 · MD
Pulmonary and Immunologic Effects of Marijuana Use on HIV and Viral Immunity
$564,473Michael D Roth · University Of California Los Angeles · R01 · FY2008 · DA
Methods for Pathway Modeling with Application to Folate
$564,437Duncan C. Thomas · University Of Southern California · R01 · FY2011 · ES
Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern Appalachia
$564,366William A Zule · Research Triangle Institute · UG3 · FY2017 · DA
Alcohol Research Consortium in HIV: Implementation Research Arm
$564,235Geetanjali Chander · Johns Hopkins University · P01 · FY2025 · AA
Neurobehavioral Deficits in HIV/HCV Infection Pre/Post Anti-HCV Therapy
$564,172Charles H Hinkin · Brentwood Biomedical Research Institute · R01 · FY2012 · MH
Genetic Regulation of Nonalcoholic Fatty Liver Disease
$564,108Marisa Wong Medina · University Of California, San Francisco · R01 · FY2022 · DK
Non-invasive screening of diabetics for advanced fibrosis due to NAFLD
$564,086Rohit Loomba · University Of California, San Diego · R01 · FY2020 · DK
Towards Translation of MU-CN29: New Therapeutic Nanoparticle for Drug-Resistant NSCLC
$563,952Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2025 · CA
TMEM55B as a molecular determinant of NAFLD
$563,952Marisa Wong Medina · University Of California, San Francisco · R56 · FY2024 · DK
Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease
$563,952Rima F Kaddurah-Daouk · Duke University · U19 · FY2022 · AG
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
$563,876Carol A Casey · University Of Nebraska Medical Center · R01 · FY2020 · AA
Prenatal Anxiety and its Effects on Child Development
$563,868Thomas G O'Connor · University Of Rochester · R01 · FY2010 · MH
Red Blood Cell Endothelial Nitric Oxide Attenuates Insulin Resistance
$563,804Francis Kim · University Of Washington · R01 · FY2021 · HL
Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease
$563,804Rolf F Kletzien · Metabolic Solutions Development Co · R42 · FY2011 · AA
Metabolic impact of fructose restriction in obese children
$563,771Jean-Marc Schwarz · Touro University Of California · R01 · FY2011 · DK
Multi-level Evaluation of Racial/ethnic Disparities in Liver Disease Outcomes
$563,756Fasiha Kanwal · Baylor College Of Medicine · R01 · FY2021 · CA
Retrovial Infections of the Nervous System in Peru
$563,709Joseph Raymond Zunt · University Of Washington · R01 · FY2010 · NS
Red Blood Cell Endothelial Nitric Oxide Attenuates Insulin Resistance
$563,702Francis Kim · University Of Washington · R01 · FY2020 · HL
Red Blood Cell Endothelial Nitric Oxide Attenuates Insulin Resistance
$563,669Francis Kim · University Of Washington · R01 · FY2019 · HL
Protein Microcharacterization
$563,548Jason Williams · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Methods for Pathway Modeling with Application to Folate
$563,499Duncan C. Thomas · University Of Southern California · R01 · FY2012 · ES
IGF::OT::IGF ANALYSIS OF CHEMICAL STRUCTURES AND THERAPEUTIC ACTIVITY OF AGENTS FOR HIV AND TUBERCULOSIS (CHEMDB)
$563,409Rocco Casagrande · Gryphon Scientific, Llc · N01 · FY2015 · AI
High throughput screening of orthosteric inhibitors of flavivirus protease
$563,396Hongmin Li · University Of Arizona · R01 · FY2021 · AI
Regulation of hepatic glucose fluxes
$563,391Meredith A Hawkins · Albert Einstein College Of Medicine · R01 · FY2013 · DK